Biomarker Discovery and Validation Solution

Improve the speed and accuracy of biomarker research

IDBS is working with leading pharmaceutical, biotechnology and research organizations such as Celera, the Dana-Farber Cancer Institute and the Children's Hospital of Philadelphia to improve the speed and accuracy of biomarker discovery and validation.

The IDBS Biomarker Discovery and Validation Solution provides a powerful and flexible IT framework to search, analyze, view and compare clinical, LIMS and experimental data for biomarker research. This unified system supports any experimental technique including genome wide association studies, gene expression, microarrays, proteomics and image analysis.

The ability to integrate these techniques means that they can be used to compare results and access comparative cohorts across multiple studies, enabling better understanding of side effects and treatment responses.

By providing a central, secure, scalable and searchable data warehouse, organizations can improve their scientific productivity by ensuring experiments are not repeated, relevant data can be easily found and reports can be generated quickly.

• Smart Search capabilities enable users to find their project data easily and eliminates bottlenecks between scientists and their data
• Subject cohorts can be defined easily and biomarker values and endpoints compared across studies with easy to use interactive web interfaces
• Automatically annotate putative biomarkers using third party tools such as GeneGo and Ingenuity, and public sources
• Delivers enhanced literature searching to accelerate biomarker validation by providing a more focused set of search results